Piramal Glass for sale at USD800 million

Indian container and pharmaceutical glassmaker Piramal Glass is for sale.

The company has appointed Bank of America and Axis Capital to find a buyer and has already approached several multi-national glass manufacturers for their interest in an $800 million deal.

Organisations approached include German container and pharmaceutical manufacturer Gerresheimer and French groups Saverglass and Verescence.

Piramal Glass operates four manufacturing plants: two in India, and one each in Sri Lanka and the USA. According to its website it makes 1475 tonnes of glass a day with 12 furnaces and 65 production lines.

It recently completed the first stage of its digital transformation in its plants and worked with companies including Microsoft to implement the new technology.

It makes glass packaging for the global cosmetics, perfumery, skin-care, food, and beverage sectors.

Piramal Glass said: “Piramal Glass India, a privately held company, is exploring a potential equity capital raise from financial partner/s to augment its accelerated growth strategy.

"PGPL believes that there are emerging opportunities arising out of market consolidation which makes it an opportune time to leverage its capabilities for both organic & inorganic growth.”

13.08.2020,

此网站新闻材料的版权属于公司或第三方的新闻提供者,其所有权利保留。所有新闻材料对其访问者只能限于其本人使用,并且使用此材料的风险由其使用者独自自行承担。严禁对新闻材料进行再次发布和其它商业利用. 作为商业贸易的用途。如果新闻材料由第三方提供,当应用此新闻材料时,每个使用者都同意遵守,并且受此特定的项目的约束。Glass Global并不代表及认可新闻材料中所包含的内容及新闻中的外部网站的内容的准确性及可靠性。

Should the content or the design of these sites violate third parties rights or legal prescriptions, we kindly ask you to send us a respective message without invoice or cost. We guarantee that passages where the claim is considered as justified will be removed immediately, without any necessity to involve any lawyer into this issue. We will reject any claim caused by submission of a honorary note in this regard without any prior contact and confirmation of the issueby us and we reserve the right ssue counter claim ourselves because of violation of aforesaid conditions.